This pipeline computes the correlation between significantly recurrent gene mutations and selected clinical features.
Testing the association between mutation status of 19 genes and 15 clinical features across 178 patients, no significant finding detected with Q value < 0.25.
-
No gene mutations related to clinical features.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
PATHOLOGIC STAGE |
PATHOLOGY T STAGE |
PATHOLOGY N STAGE |
PATHOLOGY M STAGE |
GENDER |
RADIATION THERAPY |
KARNOFSKY PERFORMANCE SCORE |
HISTOLOGICAL TYPE |
NUMBER PACK YEARS SMOKED |
YEAR OF TOBACCO SMOKING ONSET |
RESIDUAL TUMOR |
RACE | ETHNICITY | ||
nMutated (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Wilcoxon-test | Fisher's exact test | Wilcoxon-test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
TP53 | 145 (81%) | 33 |
0.0419 (1.00) |
0.708 (1.00) |
0.99 (1.00) |
0.253 (1.00) |
0.337 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.6 (1.00) |
0.663 (1.00) |
0.426 (1.00) |
0.806 (1.00) |
0.239 (1.00) |
0.401 (1.00) |
1 (1.00) |
CDKN2A | 26 (15%) | 152 |
0.0992 (1.00) |
0.595 (1.00) |
0.953 (1.00) |
0.437 (1.00) |
0.496 (1.00) |
1 (1.00) |
0.812 (1.00) |
0.74 (1.00) |
0.443 (1.00) |
0.618 (1.00) |
0.798 (1.00) |
0.624 (1.00) |
0.877 (1.00) |
0.194 (1.00) |
0.397 (1.00) |
NFE2L2 | 27 (15%) | 151 |
0.929 (1.00) |
0.793 (1.00) |
0.751 (1.00) |
0.531 (1.00) |
0.831 (1.00) |
1 (1.00) |
0.161 (1.00) |
0.325 (1.00) |
0.345 (1.00) |
0.633 (1.00) |
0.043 (1.00) |
0.904 (1.00) |
0.496 (1.00) |
0.686 (1.00) |
1 (1.00) |
MLL2 | 36 (20%) | 142 |
0.176 (1.00) |
0.826 (1.00) |
0.875 (1.00) |
0.848 (1.00) |
0.809 (1.00) |
0.495 (1.00) |
1 (1.00) |
0.368 (1.00) |
0.461 (1.00) |
0.668 (1.00) |
0.894 (1.00) |
0.569 (1.00) |
0.65 (1.00) |
0.0877 (1.00) |
0.438 (1.00) |
KEAP1 | 22 (12%) | 156 |
0.511 (1.00) |
0.817 (1.00) |
0.981 (1.00) |
0.508 (1.00) |
0.883 (1.00) |
1 (1.00) |
0.8 (1.00) |
0.22 (1.00) |
0.152 (1.00) |
0.228 (1.00) |
0.246 (1.00) |
0.445 (1.00) |
0.839 (1.00) |
0.392 (1.00) |
0.355 (1.00) |
PTEN | 14 (8%) | 164 |
0.231 (1.00) |
0.752 (1.00) |
0.233 (1.00) |
0.612 (1.00) |
0.272 (1.00) |
0.2 (1.00) |
1 (1.00) |
0.693 (1.00) |
0.879 (1.00) |
1 (1.00) |
0.815 (1.00) |
0.978 (1.00) |
0.295 (1.00) |
1 (1.00) |
0.24 (1.00) |
PIK3CA | 27 (15%) | 151 |
0.242 (1.00) |
0.57 (1.00) |
0.16 (1.00) |
0.103 (1.00) |
0.718 (1.00) |
0.398 (1.00) |
0.161 (1.00) |
1 (1.00) |
0.694 (1.00) |
1 (1.00) |
0.499 (1.00) |
0.963 (1.00) |
1 (1.00) |
0.0264 (1.00) |
1 (1.00) |
RB1 | 12 (7%) | 166 |
0.83 (1.00) |
0.553 (1.00) |
0.947 (1.00) |
0.827 (1.00) |
0.321 (1.00) |
1 (1.00) |
0.306 (1.00) |
1 (1.00) |
0.402 (1.00) |
0.053 (1.00) |
0.0746 (1.00) |
0.27 (1.00) |
0.261 (1.00) |
0.619 (1.00) |
1 (1.00) |
CYP11B1 | 15 (8%) | 163 |
0.0512 (1.00) |
0.407 (1.00) |
0.319 (1.00) |
1 (1.00) |
0.0348 (1.00) |
1 (1.00) |
0.36 (1.00) |
0.155 (1.00) |
0.191 (1.00) |
0.415 (1.00) |
0.838 (1.00) |
0.697 (1.00) |
0.478 (1.00) |
0.042 (1.00) |
1 (1.00) |
NOTCH1 | 14 (8%) | 164 |
0.298 (1.00) |
0.967 (1.00) |
0.161 (1.00) |
0.0417 (1.00) |
0.439 (1.00) |
1 (1.00) |
0.527 (1.00) |
0.616 (1.00) |
0.234 (1.00) |
1 (1.00) |
0.955 (1.00) |
0.393 (1.00) |
0.77 (1.00) |
0.618 (1.00) |
1 (1.00) |
ASB5 | 9 (5%) | 169 |
0.223 (1.00) |
0.131 (1.00) |
0.875 (1.00) |
1 (1.00) |
0.53 (1.00) |
1 (1.00) |
1 (1.00) |
0.594 (1.00) |
0.583 (1.00) |
0.031 (1.00) |
0.195 (1.00) |
0.715 (1.00) |
0.613 (1.00) |
0.51 (1.00) |
0.112 (1.00) |
IRF6 | 6 (3%) | 172 |
0.569 (1.00) |
1 (1.00) |
0.261 (1.00) |
0.125 (1.00) |
0.177 (1.00) |
1 (1.00) |
0.655 (1.00) |
0.543 (1.00) |
1 (1.00) |
0.769 (1.00) |
0.47 (1.00) |
0.158 (1.00) |
1 (1.00) |
1 (1.00) |
|
EP300 | 8 (4%) | 170 |
0.845 (1.00) |
0.0401 (1.00) |
0.689 (1.00) |
0.153 (1.00) |
0.48 (1.00) |
1 (1.00) |
0.683 (1.00) |
0.464 (1.00) |
1 (1.00) |
0.147 (1.00) |
0.964 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
|
CPS1 | 24 (13%) | 154 |
0.553 (1.00) |
0.578 (1.00) |
0.228 (1.00) |
0.372 (1.00) |
0.164 (1.00) |
1 (1.00) |
1 (1.00) |
0.489 (1.00) |
0.367 (1.00) |
0.0334 (1.00) |
0.817 (1.00) |
0.794 (1.00) |
0.745 (1.00) |
0.663 (1.00) |
1 (1.00) |
ARID1A | 13 (7%) | 165 |
0.755 (1.00) |
0.89 (1.00) |
0.0397 (1.00) |
0.135 (1.00) |
0.684 (1.00) |
1 (1.00) |
0.189 (1.00) |
0.357 (1.00) |
0.0612 (1.00) |
0.495 (1.00) |
0.11 (1.00) |
1 (1.00) |
0.161 (1.00) |
1 (1.00) |
|
SLC28A1 | 9 (5%) | 169 |
0.339 (1.00) |
0.0962 (1.00) |
0.873 (1.00) |
0.125 (1.00) |
0.729 (1.00) |
1 (1.00) |
1 (1.00) |
0.593 (1.00) |
0.272 (1.00) |
0.11 (1.00) |
1 (1.00) |
0.615 (1.00) |
1 (1.00) |
||
POLR2B | 6 (3%) | 172 |
0.0332 (1.00) |
0.0948 (1.00) |
0.809 (1.00) |
1 (1.00) |
0.66 (1.00) |
1 (1.00) |
0.655 (1.00) |
0.464 (1.00) |
0.727 (1.00) |
1 (1.00) |
0.797 (1.00) |
0.841 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
HRAS | 5 (3%) | 173 |
0.652 (1.00) |
0.274 (1.00) |
0.244 (1.00) |
0.502 (1.00) |
0.796 (1.00) |
0.0872 (1.00) |
0.609 (1.00) |
1 (1.00) |
0.159 (1.00) |
0.592 (1.00) |
0.492 (1.00) |
1 (1.00) |
0.174 (1.00) |
1 (1.00) |
|
PI16 | 7 (4%) | 171 |
0.87 (1.00) |
0.562 (1.00) |
0.444 (1.00) |
0.526 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.571 (1.00) |
0.218 (1.00) |
0.447 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
-
Mutation data file = sample_sig_gene_table.txt from Mutsig_2CV pipeline
-
Processed Mutation data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/LUSC-TP/22595691/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/LUSC-TP/22506957/LUSC-TP.merged_data.txt
-
Number of patients = 178
-
Number of significantly mutated genes = 19
-
Number of selected clinical features = 15
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.